Clinical Trials Logo

Clinical Trial Summary

Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry. The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05594550
Study type Observational
Source Centre Hospitalier Universitaire Dijon
Contact Maxime NGUYEN
Phone 380293528
Email maxime.nguyen-soenen@chu-dijon.fr
Status Not yet recruiting
Phase
Start date October 2022
Completion date December 2022